Express ELISA for detection of mortalin

Area of Science:

• Biochemistry
• Molecular Biology
• Disease Biomarkers

Background:

• Mortalin is a stress chaperone implicated in various diseases, including cancer, diabetes, neurodegeneration, and aging.
• Elevated mortalin expression is a potential diagnostic and prognostic marker for these conditions.
• Current protein analysis methods (Western blotting, IHC, ELISA) are sensitive but time-consuming.

Purpose of the Study:

• To develop a faster and quantitative method for detecting mortalin expression.
• To improve upon existing ELISA techniques for protein analysis.

Main Methods:

• Conjugation of an anti-mortalin antibody with a luciferase enzyme.
• Development of a rapid immunoassay for mortalin detection.

Main Results:

• The developed assay provides quantitative detection of mortalin expression.
• The assay significantly reduces analysis time to approximately 3 hours.
• The method offers a rapid alternative to conventional protein analysis techniques.

Conclusions:

• The novel luciferase-conjugated antibody assay enables rapid and quantitative mortalin detection.
• This advancement offers a valuable tool for diagnosing and monitoring diseases associated with mortalin dysregulation.
• The technique has potential applications in clinical diagnostics and research settings.